MCID: PRS011
MIFTS: 23

Persian Gulf Syndrome malady

Aliases & Classifications for Persian Gulf Syndrome

Aliases & Descriptions for Persian Gulf Syndrome:

Name: Persian Gulf Syndrome 12 42 14 69
Gulf War Syndrome 12 52

External Ids:

Disease Ontology 12 DOID:4491
MeSH 42 D018923
SNOMED-CT 64 95877004
UMLS 69 C0282550

Summaries for Persian Gulf Syndrome

Disease Ontology : 12 A syndrome affecting returning military veterans and civilian workers of the Gulf War.

MalaCards based summary : Persian Gulf Syndrome, also known as gulf war syndrome, is related to autonomic dysfunction and pheochromocytoma. An important gene associated with Persian Gulf Syndrome is ADCYAP1 (Adenylate Cyclase Activating Polypeptide 1), and among its related pathways/superpathways is G alpha (s) signalling events. The drugs Doxycycline and Anti-Infective Agents have been mentioned in the context of this disorder.

Wikipedia : 71 Gulf War syndrome (GWS), also known as Gulf War illnesses (GWI) and chronic multisymptom illness (CMI),... more...

Related Diseases for Persian Gulf Syndrome

Diseases related to Persian Gulf Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 autonomic dysfunction 10.0
2 pheochromocytoma 9.9 ADCYAP1 VIP
3 multiple chemical sensitivity 9.8
4 chronic fatigue syndrome 9.8
5 dysautonomia 9.8
6 microphthalmia with coloboma 5 9.8 ADCYAP1 VIP
7 orofaciodigital syndrome 9.2 ADCYAP1 ARHGEF1 PON1 TNFRSF8 VIP

Graphical network of the top 20 diseases related to Persian Gulf Syndrome:



Diseases related to Persian Gulf Syndrome

Symptoms & Phenotypes for Persian Gulf Syndrome

Drugs & Therapeutics for Persian Gulf Syndrome

Drugs for Persian Gulf Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 78)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxycycline Approved, Investigational, Vet_approved Phase 3 564-25-0 54671203
2 Anti-Infective Agents Phase 3,Phase 1
3 Anti-Bacterial Agents Phase 3
4 Antibiotics, Antitubercular Phase 3
5 Antimalarials Phase 3
6 Antiparasitic Agents Phase 3
7 Antiprotozoal Agents Phase 3
8 Antitubercular Agents Phase 3
9
Menthol Approved Phase 1, Phase 2 2216-51-5 16666
10
Coal tar Approved Phase 1, Phase 2 8007-45-2
11
Resveratrol Experimental, Investigational Phase 2 501-36-0, 955365-80-7 24856436 445154
12 Antioxidants Phase 2,Phase 1
13 Peripheral Nervous System Agents Phase 1, Phase 2
14 Protective Agents Phase 2
15 Analgesics Phase 1, Phase 2
16 Analgesics, Non-Narcotic Phase 1, Phase 2
17 Anti-Inflammatory Agents Phase 1, Phase 2
18 Anti-Inflammatory Agents, Non-Steroidal Phase 1, Phase 2
19 Antirheumatic Agents Phase 1, Phase 2
20
Curcumin Phase 1, Phase 2 458-37-7 969516
21 Adjuvants, Immunologic Phase 2
22 Antineoplastic Agents, Phytogenic Phase 2
23 Platelet Aggregation Inhibitors Phase 2
24 Turmeric extract Phase 2
25 Lactoferrin Phase 2
26 Muramidase Phase 2
27 Pharmaceutical Solutions Phase 2
28 Epimedium Nutraceutical Phase 2
29 Fisetin Nutraceutical Phase 2
30 Horny Goat Weed Nutraceutical Phase 2
31 Indian Frankincense Nutraceutical Phase 2
32
Luteolin Nutraceutical Phase 2 491-70-3 5280445
33 Pycnogenols Nutraceutical Phase 2
34 Reishi Nutraceutical Phase 2
35
St. John's Wort Nutraceutical Phase 2 84082-80-4
36 Stinging Nettle Nutraceutical Phase 2
37 Turmeric Nutraceutical Phase 2
38
Lactulose Approved Phase 1 4618-18-2 11333
39
Rifaximin Approved, Investigational Phase 1 80621-81-4 6436173
40
Folic Acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
41
Niacin Approved, Investigational, Nutraceutical Phase 1 59-67-6 938
42
Nicotinamide Approved, Nutraceutical Phase 1 98-92-0 936
43 Gastrointestinal Agents Phase 1
44 Nucleic Acid Synthesis Inhibitors Phase 1
45 Antimetabolites Phase 1
46 Hypolipidemic Agents Phase 1
47 Lipid Regulating Agents Phase 1
48 Micronutrients Phase 1
49 Nicotinic Acids Phase 1
50 Trace Elements Phase 1

Interventional clinical trials:

(show all 30)
id Name Status NCT ID Phase
1 Exercise and Behavioral Therapy Trial (EBT). Completed NCT00007748 Phase 3
2 Antibiotic Treatment of Gulf War Veterans' Illnesses Completed NCT00007735 Phase 3
3 rTMS for the Treatment of Chronic Pain in GW1 Veterans Terminated NCT01608321 Phase 3
4 Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI) Completed NCT00810368 Phase 2
5 Acupuncture in the Treatment of Gulf War Illness Completed NCT01305811 Phase 1, Phase 2
6 Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms Completed NCT01543997 Phase 2
7 Glutathione vs. Curcumin Clinical Trial Recruiting NCT02848417 Phase 1, Phase 2
8 Scalp Application of Red and Near-Infrared Light, From Light-Emitting Diodes (LED) to Improve Thinking and Memory in Veterans With Gulf War Illnesses Recruiting NCT01782378 Phase 2
9 Effects of Botanical Microglia Modulators in Gulf War Illness Recruiting NCT02909686 Phase 2
10 Gulf War Illness Nasal Irrigation Study Active, not recruiting NCT01700725 Phase 2
11 Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex Unknown status NCT00956150 Phase 1
12 Gulf War Illness: Evaluation of an Innovative Detoxification Program Completed NCT01672710 Phase 1
13 Influenza Vaccination in Fibromyalgia Patients Unknown status NCT01465477
14 Mechanisms of Mitochondrial Defects in Gulf War Syndrome Completed NCT01264471
15 Mindfulness-Based Stress Reduction for Gulf War Syndrome Completed NCT01267045
16 Effects of Low Dose Naltrexone in Fibromyalgia Completed NCT00568555
17 Exercise in Gulf War Illness (GWI) Completed NCT01291758
18 Investigate Olfactory Functioning as a Possible Proxy for Neurotoxic Exposure in Cohorts of Deployed and Non-Deployed Gulf War-Era Veterans. Completed NCT00007514
19 Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment Completed NCT00252629
20 Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress Completed NCT00018707
21 Telemedicine Treatment for Veterans With Gulf War Illness Completed NCT00129454
22 Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF) Completed NCT01437891
23 Study of Gulf War Illness (GWI) by Comparing GWI and Healthy Veterans Completed NCT00810225
24 Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome Completed NCT00100425
25 Hyporeactivity and Gulf War Illness Completed NCT00100412
26 Gulf War Digestive Health Study Completed NCT00680836
27 Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans Recruiting NCT02075489
28 Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS Recruiting NCT03030794
29 Mitochondrial Cocktail for Gulf War Illness Not yet recruiting NCT02804828
30 Gulf War 1 Veteran Healthcare Satisfaction Withdrawn NCT01703767

Search NIH Clinical Center for Persian Gulf Syndrome

Cochrane evidence based reviews: persian gulf syndrome

Genetic Tests for Persian Gulf Syndrome

Anatomical Context for Persian Gulf Syndrome

Publications for Persian Gulf Syndrome

Articles related to Persian Gulf Syndrome:

id Title Authors Year
1
Cognitive performance and cerebrohemodynamics associated with the Persian Gulf Syndrome. ( 12479508 )
2001
2
Al Eskan disease: Persian Gulf syndrome. ( 9002695 )
1997
3
Al Eskan disease: Persian Gulf syndrome. ( 9121655 )
1997
4
Beef allergy and the Persian Gulf syndrome. ( 8569540 )
1995
5
NIH panel rejects Persian Gulf syndrome. ( 8164748 )
1994

Variations for Persian Gulf Syndrome

Expression for Persian Gulf Syndrome

Search GEO for disease gene expression data for Persian Gulf Syndrome.

Pathways for Persian Gulf Syndrome

Pathways related to Persian Gulf Syndrome according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.79 ADCYAP1 VIP

GO Terms for Persian Gulf Syndrome

Biological processes related to Persian Gulf Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 regulation of protein localization GO:0032880 8.96 ADCYAP1 VIP
2 positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway GO:0010579 8.62 ADCYAP1 VIP

Molecular functions related to Persian Gulf Syndrome according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.96 ADCYAP1 VIP
2 neuropeptide hormone activity GO:0005184 8.62 ADCYAP1 VIP

Sources for Persian Gulf Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....